SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    J.F. Chen, K. H. Yang, Z.L. Zhang, H.C. Chang, Y. Chen, H. Sowa, S. Gürbüz, A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia, Osteoporosis International, 2015, 26, 1, 11

    CrossRef

  2. 2
    Enrique Gómez-Barrena, Philippe Rosset, Daniel Lozano, Julien Stanovici, Christian Ermthaller, Florian Gerbhard, Bone fracture healing: Cell therapy in delayed unions and nonunions, Bone, 2015, 70, 93

    CrossRef

  3. 3
    Michael Pensak, Seung-Hyun Hong, Alex Dukas, Jennifer Bayron, Brian Tinsley, Ashish Jain, Amy Tang, David Rowe, Jay R. Lieberman, Combination therapy with PTH and DBM cannot heal a critical sized murine femoral defect, Journal of Orthopaedic Research, 2015, 33, 7
  4. 4
    Joseph M. Lane, Commentary: Intermittent teriparatide enhancement of bone graft healing in a rat model of spinal glucocorticoid-induced osteoporosis, The Spine Journal, 2015, 15, 2, 307

    CrossRef

  5. 5
    Tsan-Wen Huang, Tien-Yu Yang, Kuo-Chin Huang, Kuo-Ti Peng, Mel S. Lee, Robert Wen-Wei Hsu, Effect of Teriparatide on Unstable Pertrochanteric Fractures, BioMed Research International, 2015, 2015, 1

    CrossRef

  6. 6
    Yoshihiro Dogaki, Sang Yang Lee, Takahiro Niikura, Takaaki Koga, Etsuko Okumachi, Kotaro Nishida, Ryosuke Kuroda, Masahiro Kurosaka, Effects of parathyroid hormone 1-34 on osteogenic and chondrogenic differentiation of human fracture haematoma-derived cells in vitro, Journal of Tissue Engineering and Regenerative Medicine, 2015, 9, 6
  7. 7
    Vedavathi Madhu, Allison Kilanski, Nikitha Reghu, Abhijit S. Dighe, Quanjun Cui, Expression of CD105 and CD34 receptors controls BMP-induced in vitro mineralization of mouse adipose-derived stem cells but does not predict their in vivo bone-forming potential, Journal of Orthopaedic Research, 2015, 33, 5
  8. 8
    A. Capone, G. Marongiu, R. Sirianni, L’osteogenesi riparativa, LO SCALPELLO-OTODI Educational, 2015, 29, 1, 2

    CrossRef

  9. 9
    Laura Kyllönen, Matteo D’Este, Mauro Alini, David Eglin, Local drug delivery for enhancing fracture healing in osteoporotic bone, Acta Biomaterialia, 2015, 11, 412

    CrossRef

  10. 10
    Liping Wang, Edward C Hsiao, Shirley Lieu, Mark Scott, O'Carroll Dylan, Ashley Urrutia, Bruce R Conklin, Celine Colnot, Robert A Nissenson, Loss of Gi G-Protein-Coupled Receptor Signaling in Osteoblasts Accelerates Bone Fracture Healing, Journal of Bone and Mineral Research, 2015, 30, 7
  11. 11
    A Spanou, GP Lyritis, E Chronopoulos, S Tournis, Management of bisphosphonate-related osteonecrosis of the jaw: a literature review, Oral Diseases, 2015, 21, 5
  12. 12
    J. Tracy Watson, Daemeon A. Nicolaou, Orthobiologics in the Augmentation of Osteoporotic Fractures, Current Osteoporosis Reports, 2015, 13, 1, 22

    CrossRef

  13. 13
    Youngwoo Kim, Chiaki Tanaka, Hiroshi Tada, Hiroshi Kanoe, Takaaki Shirai, Radiographic features of teriparatide-induced healing of femoral fractures, Bone Reports, 2015,

    CrossRef

  14. 14
    Gao Feng, Zhang Chang-Qing, Chai Yi-Min, Li Xiao-Lin, Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats, International Immunopharmacology, 2015, 24, 1, 7

    CrossRef

  15. 15
    Edna Mancilla, Jill Brodsky, Samir Mehta, Robert Pignolo, Michael Levine, Teriparatide as a Systemic Treatment for Lower Extremity Nonunion Fractures: A Case Series, Endocrine Practice, 2015, 21, 2, 136

    CrossRef

  16. 16
    Eric J Campbell, Graeme M Campbell, David A Hanley, The effect of parathyroid hormone and teriparatide on fracture healing, Expert Opinion on Biological Therapy, 2015, 15, 1, 119

    CrossRef

  17. 17
    Shinichi Nakatoh, The importance of assessing the rate of bone turnover and the balance between bone formation and bone resorption during daily teriparatide administration for osteoporosis: a pilot study, Journal of Bone and Mineral Metabolism, 2015,

    CrossRef

  18. 18
    Anthony F. De Giacomo, Thomas A. Einhorn, The Parathyroids, 2015,

    CrossRef

  19. 19
    Jörgen Nordenström, Robert Marcus, The Parathyroids, 2015,

    CrossRef

  20. 20
    David Goltzman, The Parathyroids, 2015,

    CrossRef

  21. 21
    Suzanne Stewart, Stephanie J. Bryant, Jaimo Ahn, Kurt D. Hankenson, Translational Regenerative Medicine, 2015,

    CrossRef

  22. 22
    Srinivas K. Rao, Anitha P. Rao, A literature review and case series of accelerating fracture healing in postmenopausal osteoporotic working women, Journal of Orthopaedics, 2014, 11, 3, 150

    CrossRef

  23. 23
    Sune Larsson, Nicola L. Fazzalari, Anti-osteoporosis therapy and fracture healing, Archives of Orthopaedic and Trauma Surgery, 2014, 134, 2, 291

    CrossRef

  24. 24
    R. Lane Smith, Edward M. Schwarz, Are Biologic Treatments a Potential Approach to Wear- and Corrosion-related Problems?, Clinical Orthopaedics and Related Research®, 2014, 472, 12, 3740

    CrossRef

  25. 25
    Jakob Holm, Pia Eiken, Lars Hyldstrup, Jens-Erik Jensen, Atypical Femoral Fracture in an Osteogenesis Imperfecta Patient Successfully Treated with Teriparatide, Endocrine Practice, 2014, 20, 10, e187

    CrossRef

  26. 26
    Joon Soon Kang, Ye Yeon Won, Jong Oh Kim, Byeong Woo Min, Kee Haeng Lee, Kwan Kyu Park, Joo Hyun Song, Young Tae Kim, Geon Ho Kim, Atypical femoral fractures after anti-osteoporotic medication: a Korean multicenter study, International Orthopaedics, 2014, 38, 6, 1247

    CrossRef

  27. 27
    Wesley H. Bronson, I. David Kaye, Kenneth A. Egol, Atypical Femur Fractures: A Review, Current Osteoporosis Reports, 2014, 12, 4, 446

    CrossRef

  28. 28
    Elizabeth Shane, David Burr, Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David W Dempster, Peter R Ebeling, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O'Keefe, Socrates Papapoulos, Tet Sen Howe, Marjolein CH van der Meulen, Robert S Weinstein, Michael P Whyte, Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research, 2014, 29, 1
  29. 29
    Thomas A. Einhorn, Yelena Bogdan, Paul Tornetta, Bisphosphonate-Associated Fractures of the Femur, Journal of Orthopaedic Trauma, 2014, 28, 7, 433

    CrossRef

  30. 30
    Koji Nozaka, Yoichi Shimada, Naohisa Miyakoshi, Shin Yamada, Michio Hongo, Yuji Kasukawa, Hidetomo Saito, Hiroaki Kijima, Combined effect of teriparatide and low-intensity pulsed ultrasound for nonunion: a case report, BMC Research Notes, 2014, 7, 1, 317

    CrossRef

  31. 31
    Jin Park, Seong Yup Jeong, Complications and Outcomes of Minimally Invasive Percutaneous Plating for Proximal Humeral Fractures, Clinics in Orthopedic Surgery, 2014, 6, 2, 146

    CrossRef

  32. 32
    K. M. Kim, W. Park, S. Y. Oh, H.-J. Kim, W. Nam, S.-K. Lim, Y. Rhee, I. H. Cha, Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw, Osteoporosis International, 2014, 25, 5, 1625

    CrossRef

  33. 33
    Shinichiro Kuroshima, Rodan B. Mecano, Ryuichiro Tanoue, Kiyono Koi, Junro Yamashita, Distinctive Tooth-Extraction Socket Healing: Bisphosphonate Versus Parathyroid Hormone Therapy, Journal of Periodontology, 2014, 85, 1, 24

    CrossRef

  34. 34
    S. Kuroshima, P. Entezami, L. K. McCauley, J. Yamashita, Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing, Osteoporosis International, 2014, 25, 3, 1141

    CrossRef

  35. 35
    Fredrik Agholme, Brandon Macias, Matt Hamang, Jonathan Lucchesi, Mary D. Adrian, Stuart Kuhstoss, Anita Harvey, Masahiko Sato, Per Aspenberg, Efficacy of a sclerostin antibody compared to a low dose of PTH on metaphyseal bone healing, Journal of Orthopaedic Research, 2014, 32, 3
  36. 36
    Thomas A. Einhorn, Louis C. Gerstenfeld, Fracture healing: mechanisms and interventions, Nature Reviews Rheumatology, 2014, 11, 1, 45

    CrossRef

  37. 37
    Naohisa Miyakoshi, Toshiaki Aizawa, Satoshi Sasaki, Shigeru Ando, Shigeto Maekawa, Hiroshi Aonuma, Hiroyuki Tsuchie, Hiroshi Sasaki, Yuji Kasukawa, Yoichi Shimada, Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide, Journal of Bone and Mineral Metabolism, 2014,

    CrossRef

  38. 38
    Daniel Fernando Pereira Vasconcelos, Marcelo Rocha Marques, Bruno Braga Benatti, Silvana Pereira Barros, Francisco Humberto Nociti Júnior, Pedro Duarte Novaes, Intermittent Parathyroid Hormone Administration Improves Periodontal Healing in Rats, Journal of Periodontology, 2014, 85, 5, 721

    CrossRef

  39. 39
    J.-H. Park, K.-C. Kang, D.-E. Shin, Y.-G. Koh, J.-S. Son, B.-H. Kim, Preventive effects of conservative treatment with short-term teriparatide on the progression of vertebral body collapse after osteoporotic vertebral compression fracture, Osteoporosis International, 2014, 25, 2, 613

    CrossRef

  40. 40
    Dafang Zhang, Anish Potty, Parth Vyas, Joseph Lane, The Role of Recombinant PTH in Human Fracture Healing, Journal of Orthopaedic Trauma, 2014, 28, 1, 57

    CrossRef

  41. 41
    Young-Soo Shin, Ha-Joon Jung, Abhijit Prakash Savale, Seung-Beom Han, Unusual Excessive Callus Formation in the Intertrochanteric Fracture Treated with Teriparatide, Hip & Pelvis, 2014, 26, 1, 41

    CrossRef

  42. 42
    Mauricio Kfuri, Rafael Lara de Freitas, Bruno Bellaguarda Batista, Rodrigo Salim, Marcello Teixeira Castiglia, Ricardo Antonio Tavares, Paulo Henrique Araújo, Updates in biological therapies for knee injuries: bone, Current Reviews in Musculoskeletal Medicine, 2014, 7, 3, 220

    CrossRef

  43. 43
    Hisakazu Tachiiri, Yoshiki Okuda, Takahito Yamasaki, Torao Kusakabe, Weekly teriparatide administration for the treatment of delayed union: a report of two cases, Archives of Osteoporosis, 2014, 9, 1

    CrossRef

  44. 44
    Fumio Fukuda, Naoaki Kurinomaru, Akihiko Hijioka, Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures, Biologics in Therapy, 2014, 4, 1-2, 73

    CrossRef

  45. 45
    W. Hofstetter, R. Egli, Reference Module in Biomedical Sciences, 2014,

    CrossRef

  46. 46
    A. Méndez-Gil, S. Prat-Fabregat, A. Domingo-Trepat, M. Navarro-López, P. Camacho-Carrasco, A. Carreño-Delgado, J.A. Zumbado-Dijeres, R. García-Elvira, M. Ríos-Martín, R. García-Tarriño, O. Ares-Rodríguez, J.R. Ballesteros-Betancourt, S. Suso-Vergara, ¿Qué sabemos de las fracturas atípicas en los pacientes en tratamiento con bifosfonatos? Revisión bibliográfica a raíz de una serie de casos, Revista Española de Cirugía Ortopédica y Traumatología, 2013, 57, 2, 95

    CrossRef

  47. 47
    Per Aspenberg, Annotation: Parathyroid hormone and fracture healing, Acta Orthopaedica, 2013, 84, 1, 4

    CrossRef

  48. 48
    Raúl Parrón Cambero, Antonio Rey López, Félix Tomé-Bermejo, Roberto Cibantos Martínez, Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates, European Journal of Orthopaedic Surgery & Traumatology, 2013, 23, S2, 219

    CrossRef

  49. 49
    Vikram Sathyendra, Michael Darowish, Basic Science of Bone Healing, Hand Clinics, 2013, 29, 4, 473

    CrossRef

  50. 50
    Anas Saleh, Vishal V. Hegde, Anish G. Potty, Joseph M. Lane, Bisphosphonate Therapy and Atypical Fractures, Orthopedic Clinics of North America, 2013, 44, 2, 137

    CrossRef

  51. 51
    K.-H. William Lau, Vishal Kothari, Amitava Das, Xiao-Bing Zhang, David J. Baylink, Cellular and molecular mechanisms of accelerated fracture healing by COX2 gene therapy, Bone, 2013, 53, 2, 369

    CrossRef

  52. 52
    G. Marongiu, M. Mastio, A. Capone, Current options to surgical treatment in osteoporotic fractures, Aging Clinical and Experimental Research, 2013, 25, S1, 15

    CrossRef

  53. 53
    Tsung-Li Lin, Shyu-Jye Wang, Yi-Chin Fong, Chin-Jung Hsu, Horng-Chaung Hsu, Chun-Hao Tsai, Discontinuation of alendronate and administration of bone-forming agents after surgical nailing may promote union of atypical femoral fractures in patients on long-term alendronate therapy, BMC Research Notes, 2013, 6, 1, 11

    CrossRef

  54. 54
    Young-Kyun Lee, Byung-Ho Yoon, Kyung-Hoi Koo, Epidemiology and Clinical Features of Atypical Femoral Fractures, Journal of the Korean Orthopaedic Association, 2013, 48, 3, 175

    CrossRef

  55. 55
    Umberto Tarantino, Luca Saturnino, Alessandro Scialdoni, Maurizio Feola, Federico Maria Liuni, Valerio Tempesta, Pietro Pistillo, Fracture healing in elderly patients: new challenges for antiosteoporotic drugs, Aging Clinical and Experimental Research, 2013, 25, S1, 105

    CrossRef

  56. 56
    Maria Luisa Brandi, Healing of the bone with anti-fracture drugs, Expert Opinion on Pharmacotherapy, 2013, 14, 11, 1441

    CrossRef

  57. 57
    F.M. Stuby, A. Schäffler, T. Haas, B. König, U. Stöckle, T. Freude, Insuffizienzfrakturen des Beckenrings, Der Unfallchirurg, 2013, 116, 4, 351

    CrossRef

  58. 58
    Yong-Chan Ha, Young-Kyun Lee, Byung-Woo Min, Medical Treatment of Atypical Femoral Fracture, Journal of the Korean Orthopaedic Association, 2013, 48, 3, 180

    CrossRef

  59. 59
    Ángel Oteo-Álvaro, María T. Marín, Nonunion of the humeral shaft successfully treated with teriparatide [rh (1-34) PTH], Case Reports in Clinical Medicine, 2013, 02, 01, 11

    CrossRef

  60. 60
    B. F. Ricciardi, J. Paul, A. Kim, L. A. Russell, J. M. Lane, Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease, Osteoporosis International, 2013, 24, 2, 423

    CrossRef

  61. 61
    Marilyn Augustine, Mara J. Horwitz, Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs as Therapies for Osteoporosis, Current Osteoporosis Reports, 2013, 11, 4, 400

    CrossRef

  62. 62
    Shinichiro Kuroshima, Zeina Al-Salihi, Junro Yamashita, Parathyroid Hormone Related to Bone Regeneration in Grafted and Nongrafted Tooth Extraction Sockets in Rats, Implant Dentistry, 2013, 22, 1, 71

    CrossRef

  63. 63
    Robinder S Dhillon, Chao Xie, Wakenda Tyler, Laura M Calvi, Hani A Awad, Michael J Zuscik, Regis J O'Keefe, Edward M Schwarz, PTH-enhanced structural allograft healing is associated with decreased angiopoietin-2–mediated arteriogenesis, mast cell accumulation, and fibrosis, Journal of Bone and Mineral Research, 2013, 28, 3
  64. 64
    Per Aspenberg, Special Review: Accelerating fracture repair in humans: a reading of old experiments and recent clinical trials, BoneKEy Reports, 2013, 2, 1

    CrossRef

  65. 65
    Cherie Ying Chiang, Roger M.D. Zebaze, Ali Ghasem-Zadeh, Sandra Iuliano-Burns, Andrew Hardidge, Ego Seeman, Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy, Bone, 2013, 52, 1, 360

    CrossRef

  66. 66
    Luca Pietrogrande, Emanuela Raimondo, Teriparatide in the treatment of non-unions: Scientific and clinical evidences, Injury, 2013, 44, S54

    CrossRef

  67. 67
    A. Nardi, L. Ventura, L. Cozzi, G. Tonini, R. Zennaro, M. Celi, E. Ramazzina, The bone anabolic therapy, Aging Clinical and Experimental Research, 2013, 25, S1, 121

    CrossRef

  68. 68
    Maria Ellegaard, Tina Kringelbach, Susanne Syberg, Solveig Petersen, Jens-Erik Beck Jensen, Annemarie Brüel, Niklas Rye Jørgensen, Peter Schwarz, The effect of PTH(1-34) on fracture healing during different loading conditions, Journal of Bone and Mineral Research, 2013, 28, 10
  69. 69
    R. A. Corrigan, A. Miller, M. A. McNally, M. K. Javaid, Treatment of fracture non-union in a young adult with combination anabolic and anti-resorptive bone therapy, Rheumatology, 2013, 52, 6, 1147

    CrossRef

  70. 70
    A. Méndez-Gil, S. Prat-Fabregat, A. Domingo-Trepat, M. Navarro-López, P. Camacho-Carrasco, A. Carreño-Delgado, J.A. Zumbado-Dijeres, R. García-Elvira, M. Ríos-Martín, R. García-Tarriño, O. Ares-Rodríguez, J.R. Ballesteros-Betancourt, S. Suso-Vergara, What do we know about atypical fractures in patients on bisphosphonates treatment? A literature review using a case series, Revista Española de Cirugía Ortopédica y Traumatología (English Edition), 2013, 57, 2, 95

    CrossRef

  71. 71
    Elizabeth Shane, Sundeep Khosla, David Burr, Osteoporosis, 2013,

    CrossRef

  72. 72
    Felicia Cosman, Robert Lindsay, Osteoporosis, 2013,

    CrossRef

  73. 73
    Aasis Unnanuntana, Quang V. Ton, John P. Kleimeyer, Joseph T. Nguyen, Joseph M. Lane, A Fracture Does Not Adversely Affect Bone Mineral Density Responses after Teriparatide Treatment, Clinical Orthopaedics and Related Research®, 2012, 470, 3, 927

    CrossRef

  74. 74
    Zsolt J Balogh, Marie K Reumann, Russell L Gruen, Philipp Mayer-Kuckuk, Michael A Schuetz, Ian A Harris, Belinda J Gabbe, Mohit Bhandari, Advances and future directions for management of trauma patients with musculoskeletal injuries, The Lancet, 2012, 380, 9847, 1109

    CrossRef

  75. 75
    Iñigo Etxebarria-Foronda, Edorta Esnal-Baza, Atrophic non-union of tibial fracture treated with PTH 1-84: a case report, European Orthopaedics and Traumatology, 2012, 3, 2, 141

    CrossRef

  76. 76
    Mandeep S Virk, Jay R Lieberman, Biologic adjuvants for fracture healing, Arthritis Research & Therapy, 2012, 14, 5, 225

    CrossRef

  77. 77
    Masahiko Takahata, Edward M Schwarz, Tony Chen, Regis J O'Keefe, Hani A Awad, Delayed short-course treatment with teriparatide (PTH1–34) improves femoral allograft healing by enhancing intramembranous bone formation at the graft–host junction, Journal of Bone and Mineral Research, 2012, 27, 1
  78. 78
    Maria Luisa Brandi, Drugs for bone healing, Expert Opinion on Investigational Drugs, 2012, 21, 8, 1169

    CrossRef

  79. 79
    Masahiko Takahata, Hani A. Awad, Regis J. O’Keefe, Susan V. Bukata, Edward M. Schwarz, Endogenous tissue engineering: PTH therapy for skeletal repair, Cell and Tissue Research, 2012, 347, 3, 545

    CrossRef

  80. 80
    J. Goldhahn, J.-M. Féron, J. Kanis, S. Papapoulos, J.-Y. Reginster, R. Rizzoli, W. Dere, B. Mitlak, Y. Tsouderos, S. Boonen, Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper, Calcified Tissue International, 2012, 90, 5, 343

    CrossRef

  81. 81
    Hyung Keun Song, Sung Jun Kim, Jae Hoo Lee, Kyu Hyun Yang, Intermittent Parathyroid Hormone Treatment for Stimulation of Callus Formation in Elderly Patients, Journal of the Korean Fracture Society, 2012, 25, 4, 295

    CrossRef

  82. 82
    Anas Saleh, Vishal V. Hegde, Anish G. Potty, Robert Schneider, Charles N. Cornell, Joseph M. Lane, Management Strategy for Symptomatic Bisphosphonate-Associated Incomplete Atypical Femoral Fractures, HSS Journal ®, 2012, 8, 2, 103

    CrossRef

  83. 83
    Neil A Andrews, Progress in RANK ligand biology: bone and beyond, IBMS BoneKEy, 2012, 9,

    CrossRef

  84. 84
    Mark A. Reynolds, Mary E. Aichelmann-Reidy, Protein and Peptide-Based Therapeutics in Periodontal Regeneration, Journal of Evidence Based Dental Practice, 2012, 12, 3, 118

    CrossRef

  85. 85
    Chad M Novince, Megan N Michalski, Amy J Koh, Benjamin P Sinder, Payam Entezami, Matthew R Eber, Glenda J Pettway, Thomas J Rosol, Thomas J Wronski, Ken M Kozloff, Laurie K McCauley, Proteoglycan 4: A dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism, Journal of Bone and Mineral Research, 2012, 27, 1
  86. 86
    Stefan Zwingenberger, Christophe Nich, Roberto D. Valladares, Zhenyu Yao, Maik Stiehler, Stuart B. Goodman, Recommendations and Considerations for the Use of Biologics in Orthopedic Surgery, BioDrugs, 2012, 26, 4, 245

    CrossRef

  87. 87
    Stefan Zwingenberger, Christophe Nich, Roberto D. Valladares, Zhenyu Yao, Maik Stiehler, Stuart B. Goodman, Recommendations and Considerations for the Use of Biologics in Orthopedic Surgery, BioDrugs, 2012, 26, 4, 245

    CrossRef

  88. 88
    Cristiana Capriani, Dinaz Irani, John P Bilezikian, Safety of osteoanabolic therapy: A decade of experience, Journal of Bone and Mineral Research, 2012, 27, 12
  89. 89
    Zakareya Gamie, Nectarios Korres, Andreas Leonidou, Andrew C Gray, Eleftherios Tsiridis, Sclerostin monoclonal antibodies on bone metabolism and fracture healing, Expert Opinion on Investigational Drugs, 2012, 21, 10, 1523

    CrossRef

  90. 90
    Henrik Daugaard, Brian Elmengaard, Troels Torp Andreassen, Anders Lamberg, Joan Elisabeth Bechtold, Kjeld Soballe, Systemic intermittent parathyroid hormone treatment improves osseointegration of press-fit inserted implants in cancellous bone, Acta Orthopaedica, 2012, 83, 4, 411

    CrossRef

  91. 91
    Seiji Ohtori, Gen Inoue, Sumihisa Orita, Kazuyo Yamauchi, Yawara Eguchi, Nobuyasu Ochiai, Shunji Kishida, Kazuki Kuniyoshi, Yasuchika Aoki, Junichi Nakamura, Tetsuhiro Ishikawa, Masayuki Miyagi, Hiroto Kamoda, Miyako Suzuki, Gou Kubota, Yoshihiro Sakuma, Yasuhiro Oikawa, Kazuhide Inage, Takeshi Sainoh, Masashi Takaso, Tomoyuki Ozawa, Kazuhisa Takahashi, Tomoaki Toyone, Teriparatide Accelerates Lumbar Posterolateral Fusion in Women With Postmenopausal Osteoporosis, Spine, 2012, 37, 23, E1464

    CrossRef

  92. 92
    Y.-K. Lee, Y.-C. Ha, K.-H. Koo, Teriparatide, a nonsurgical solution for femoral nonunion? A report of three cases, Osteoporosis International, 2012, 23, 12, 2897

    CrossRef

  93. 93
    Y. F. Li, C. C. Zhou, J. H. Li, E. Luo, S. S. Zhu, G. Feng, J. Hu, The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats, Osteoporosis International, 2012, 23, 4, 1463

    CrossRef

  94. 94
    M. Díez Ulloa, A patient with spondylitis ankylopoetica and neck fracture: A delay in consolidation in a conservative treatment resolved with teriparatide, Revista Española de Cirugía Ortopédica y Traumatología (English Edition), 2011, 55, 5, 378

    CrossRef

  95. 95
    Xiaohua Zeng, Hao He, Liang Zhang, Yingying Wu, Yanying Wang, Ping Gong, A potential therapeutic approach to overload-induced bone loss around implant: Parathyroid hormone (PTH), Medical Hypotheses, 2011, 77, 5, 701

    CrossRef

  96. 96
    Anna Kajsa Harding, Annette W-Dahl, Mats Geijer, Sören Toksvig-Larsen, Magnus Tägil, A single bisphosphonate infusion does not accelerate fracture healing in high tibial osteotomies, Acta Orthopaedica, 2011, 82, 4, 465

    CrossRef

  97. 97
    Tarek Sibai, Elise F. Morgan, Thomas A. Einhorn, Anabolic Agents and Bone Quality, Clinical Orthopaedics and Related Research®, 2011, 469, 8, 2215

    CrossRef

  98. 98
    Kyu Hyun Yang, Anti-osteoporotic Drugs and Fracture Healing Mechanism, Journal of the Korean Fracture Society, 2011, 24, 2, 212

    CrossRef

  99. 99
    Céline Colnot, Cell Sources for Bone Tissue Engineering: Insights from Basic Science, Tissue Engineering Part B: Reviews, 2011, 17, 6, 449

    CrossRef

  100. 100
    S. Bobo Tanner, Choosing a Treatment for Patients at the Time a Fracture is Presented, Current Osteoporosis Reports, 2011, 9, 3, 156

    CrossRef

  101. 101
    Barbara Mognetti, Silvia Marino, Alessandro Barberis, Anne-Sophie Bravo Martin, Yohann Bala, Francesco Di Carlo, Georges Boivin, Michele Portigliatti Barbos, Experimental Stimulation of Bone Healing with Teriparatide: Histomorphometric and Microhardness Analysis in a Mouse Model of Closed Fracture, Calcified Tissue International, 2011, 89, 2, 163

    CrossRef

  102. 102
    Chaoyang Li, Michael S. Ominsky, Hong-Lin Tan, Mauricio Barrero, Qing-Tian Niu, Franklin J. Asuncion, Edward Lee, Min Liu, William S. Simonet, Chris Paszty, Hua Zhu Ke, Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene, Bone, 2011, 49, 6, 1178

    CrossRef

  103. 103
    Michael S Ominsky, Chaoyang Li, Xiaodong Li, Hong L Tan, Edward Lee, Mauricio Barrero, Franklin J Asuncion, Denise Dwyer, Chun-Ya Han, Fay Vlasseros, Rana Samadfam, Jacquelin Jolette, Susan Y Smith, Marina Stolina, David L Lacey, William S Simonet, Chris Paszty, Gang Li, Hua Z Ke, Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones, Journal of Bone and Mineral Research, 2011, 26, 5
  104. 104
    Ulrike Kuchler, Tina Spilka, Katharina Baron, Stefan Tangl, Georg Watzek, Reinhard Gruber, Intermittent parathyroid hormone fails to stimulate osseointegration in diabetic rats, Clinical Oral Implants Research, 2011, 22, 5
  105. You have free access to this content105
    Rubén Cabanillas, Juan Cadiñanos, José A.F. Villameytide, Mercedes Pérez, Jesús Longo, José M. Richard, Rebeca Álvarez, Noelia S. Durán, Rafael Illán, Daniel J. González, Carlos López-Otín, Néstor–Guillermo progeria syndrome: A novel premature aging condition with early onset and chronic development caused by BANF1 mutations, American Journal of Medical Genetics Part A, 2011, 155, 11
  106. 106
    E. Michael Lewiecki, John P. Bilezikian, Sundeep Khosla, Robert Marcus, Michael R. McClung, Paul D. Miller, Nelson B. Watts, Michael Maricic, Osteoporosis Update From the 2010 Santa Fe Bone Symposium, Journal of Clinical Densitometry, 2011, 14, 1, 1

    CrossRef

  107. 107
    M. Díez Ulloa, Paciente con espondilitis anquilopoyética y fractura cervical: retardo de consolidación en un tratamiento conservador resuelto con teriparatida, Revista Española de Cirugía Ortopédica y Traumatología, 2011, 55, 5, 378

    CrossRef

  108. 108
    Wei-Peng Lin, Jinn Lin, Parathyroid hormone for osteoporosis treatment, Formosan Journal of Musculoskeletal Disorders, 2011, 2, 4, 113

    CrossRef

  109. 109
    Henrik Daugaard, Brian Elmengaard, Troels Andreassen, Joan Bechtold, Anders Lamberg, Kjeld Soballe, Parathyroid Hormone Treatment Increases Fixation of Orthopedic Implants with Gap Healing: A Biomechanical and Histomorphometric Canine Study of Porous Coated Titanium Alloy Implants in Cancellous Bone, Calcified Tissue International, 2011, 88, 4, 294

    CrossRef

  110. 110
    R. Marcus, Present at the beginning: a personal reminiscence on the history of teriparatide, Osteoporosis International, 2011, 22, 8, 2241

    CrossRef

  111. 111
    Lorraine A. Fitzpatrick, Phillipa L. Smith, Trish A. McBride, Michael A. Fries, Mohammad Hossain, Christine E. Dabrowski, David N. Gordon, Ronacaleret, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time: Results of a randomized, double-blinded, placebo-controlled Phase II clinical trial, Bone, 2011, 49, 4, 845

    CrossRef

  112. 112
    E. Michael Lewiecki, Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis, Drugs, 2011, 71, 6, 791

    CrossRef

  113. 113
    Susan V. Bukata, Systemic administration of pharmacological agents and bone repair: What can we expect, Injury, 2011, 42, 6, 605

    CrossRef

  114. 114
    David G. Reynolds, Masahiko Takahata, Amy L. Lerner, Regis J. O'Keefe, Edward M. Schwarz, Hani A. Awad, Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model, Bone, 2011, 48, 3, 562

    CrossRef

  115. 115
    Stuart L. Silverman, Keaton Nasser, Teriparitide Update, Rheumatic Disease Clinics of North America, 2011, 37, 3, 471

    CrossRef

  116. 116
    Judith Haschka, Friederike Kühne, Christian Muschitz, Thomas Pirker, Roland Kocijan, Christina Bittighofer, Angela Trubrich, Heinrich Resch, The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years, Wiener klinische Wochenschrift, 2011, 123, 21-22, 684

    CrossRef

  117. 117
    Fredrik Agholme, Hanna Isaksson, Stuart Kuhstoss, Per Aspenberg, The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions, Bone, 2011, 48, 5, 988

    CrossRef

  118. 118
    Aaron Nauth, Theodore Miclau, Mohit Bhandari, Emil H Schemitsch, Use of Osteobiologics in the Management of Osteoporotic Fractures, Journal of Orthopaedic Trauma, 2011, 25, S51

    CrossRef

  119. 119
    Fredrik Agholme, Per Aspenberg, Wnt signaling and orthopedics, an overview, Acta Orthopaedica, 2011, 82, 2, 125

    CrossRef

  120. You have free access to this content120
    Elizabeth Shane, David Burr, Peter R Ebeling, Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David Dempster, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Kenneth Koval, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O'Keefe, Socrates Papapoulos, Howe Tet Sen, Marjolein CH van der Meulen, Robert S Weinstein, Michael Whyte, Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research, Journal of Bone and Mineral Research, 2010, 25, 11
  121. 121
    Jean-Pierre Devogelaer, Yves Boutsen, Daniel H. Manicourt, Biologicals in Osteoporosis: Teriparatide and Parathyroid Hormone in Women and Men, Current Osteoporosis Reports, 2010, 8, 3, 154

    CrossRef

  122. 122
    Fredrik Agholme, Xiaodong Li, Hanna Isaksson, Hua Zhu Ke, Per Aspenberg, Sclerostin antibody treatment enhances metaphyseal bone healing in rats, Journal of Bone and Mineral Research, 2010, 25, 11
  123. 123
    Jill D. Bashutski, Robert M. Eber, Janet S. Kinney, Erika Benavides, Samopriyo Maitra, Thomas M. Braun, William V. Giannobile, Laurie K. McCauley, Teriparatide and Osseous Regeneration in the Oral Cavity, New England Journal of Medicine, 2010, 363, 25, 2396

    CrossRef

  124. 124
    Andrew Grey, Teriparatide for Bone Loss in the Jaw, New England Journal of Medicine, 2010, 363, 25, 2458

    CrossRef

  125. 125
    David E. Komatsu, Stuart J. Warden, The control of fracture healing and its therapeutic targeting: Improving upon nature, Journal of Cellular Biochemistry, 2010, 109, 2
  126. 126
    Ippokratis Pountos, Theodora Georgouli, Karen Henshaw, Howard Bird, Elena Jones, Peter V Giannoudis, The Effect of Bone Morphogenetic Protein-2, Bone Morphogenetic Protein-7, Parathyroid Hormone, and Platelet-Derived Growth Factor on the Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells Derived From Osteoporotic Bone, Journal of Orthopaedic Trauma, 2010, 24, 9, 552

    CrossRef

  127. 127
    Felicia Cosman, Susan L. Greenspan, Parathyroid Hormone Treatment for Osteoporosis,
  128. 128
    References and Notes,
  129. 129
    Michael J. Zuscik, Skeletal Healing,